VTAK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VTAK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-01), Catheter Precision's share price is $0.5104. Catheter Precision's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-5.88. Hence, Catheter Precision's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Catheter Precision's Price-to-Free-Cash-Flow or its related term are showing as below:
Catheter Precision's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.27. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-5.88.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 83.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 75.20% per year.
During the past 8 years, Catheter Precision's highest 3-Year average Free Cash Flow per Share Growth Rate was 83.50% per year. The lowest was -143.90% per year. And the median was 53.40% per year.
The historical data trend for Catheter Precision's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial | - | - | - | - | - |
Catheter Precision Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Devices subindustry, Catheter Precision's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Catheter Precision's Price-to-Free-Cash-Flow falls into.
Catheter Precision's Price-to-Free-Cash-Flow ratio for today is calculated as
Price-to-Free-Cash-Flow Ratio | = | Share Price | / | Free Cash Flow per Share (TTM) |
= | 0.5104 | / | -5.882 | |
= | N/A |
Catheter Precision's Share Price of today is $0.5104.
Catheter Precision's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.88.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price-to-Free-Cash-Flow Ratio | = | Market Cap | / | Free Cash Flow |
Catheter Precision (AMEX:VTAK) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Thank you for viewing the detailed overview of Catheter Precision's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
David A Jenkins | director, officer: Executive Chairman of Board | P.O. BOX 682838, PARK CITY UT 84068 |
Steven K Passey | officer: Chief Financial Officer | 3216 SOUTH HIGHLAND DRIVE, SUITE 200, SALT LAKE CITY UT 84117 |
James Joseph Caruso | director | 28 FIRST AVE, SEASIDE PARK NJ 08752 |
Brian Conn | officer: Chief Financial Officer | MICROISLET, INC., 6370 NANCY RIDGE DRIVE, SUITE 112, SAN DIEGO CA 92121 |
Andrew C. Jackson | officer: CFO & Secretary | 11988 EL CAMINO REAL STE. 650, SAN DIEGO CA 92130 |
Jonathan Will Mcguire | director, officer: Chief Executive Officer | 96 TALAMINE COURT, COLORADO SPRINGS CO 80907 |
Susanne Meline | director | P.O. BOX 515381, #86506, LOS ANGELES CA 90051 |
Martin J Colombatto | director | |
Richard Jr Mejia | director | 2200 FARADAY AVENUE, SUITE 100, CARLSBAD CA 92008 |
William R Enquist | director | 11810 WILLS ROAD, ALPHARETTA GA 30009 |
Joan Stafslien | director | CAREFUSION CORPORATION, 3750 TORREY VIEW COURT, SAN DIEGO CA 92130 |
Daniel Horwood | officer: General Counsel | C/O RA MEDICAL SYTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011 |
Jeffrey J Kraws | officer: Co-President | 3985 RESEARCH PARK DRIVE, ANN ARBOR MI 48108 |
Dean Irwin | director, 10 percent owner, officer: See Remarks | C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011 |
Martin Burstein | 10 percent owner | C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011 |
From GuruFocus
By ACCESSWIRE • 01-12-2024
By ACCESSWIRE • 12-05-2023
By ACCESSWIRE • 10-12-2023
By ACCESSWIRE • 01-11-2024
By ACCESSWIRE • 09-07-2023
By ACCESSWIRE • 08-25-2023
By ACCESSWIRE • 11-20-2023
By ACCESSWIRE • 08-14-2023
By ACCESSWIRE ACCESSWIRE • 05-09-2023
By ACCESSWIRE • 07-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.